[go: up one dir, main page]

ATE226832T1 - Mittel zur arzneistoffverabreichung durch iontophorese - Google Patents

Mittel zur arzneistoffverabreichung durch iontophorese

Info

Publication number
ATE226832T1
ATE226832T1 AT97110139T AT97110139T ATE226832T1 AT E226832 T1 ATE226832 T1 AT E226832T1 AT 97110139 T AT97110139 T AT 97110139T AT 97110139 T AT97110139 T AT 97110139T AT E226832 T1 ATE226832 T1 AT E226832T1
Authority
AT
Austria
Prior art keywords
iontophoresis
drug
humectant
agent
drug administration
Prior art date
Application number
AT97110139T
Other languages
English (en)
Inventor
Naruhito Higo
Hirotoshi Adachi
Kenji Mori
Katsumi Iga
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE226832T1 publication Critical patent/ATE226832T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97110139T 1996-06-20 1997-06-20 Mittel zur arzneistoffverabreichung durch iontophorese ATE226832T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18148096 1996-06-20

Publications (1)

Publication Number Publication Date
ATE226832T1 true ATE226832T1 (de) 2002-11-15

Family

ID=16101500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97110139T ATE226832T1 (de) 1996-06-20 1997-06-20 Mittel zur arzneistoffverabreichung durch iontophorese

Country Status (5)

Country Link
EP (1) EP0813879B1 (de)
CN (1) CN1171269A (de)
AT (1) ATE226832T1 (de)
CA (1) CA2208332A1 (de)
DE (1) DE69716676T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT974350E (pt) * 1996-02-07 2002-12-31 Lead Chem Co Ltd Preparacao contendo tranilast para aplicacao externa e metedo para a sua producao
EP0922467A3 (de) 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretische Verabreichung von Medikamenten
EP1965856A2 (de) 2005-12-30 2008-09-10 Tti Ellebeau, Inc. Iontophoretische systeme, vorrichtungen und verfahren zur abgabe von wirkstoffen an eine biologische schnittstelle
TW200838576A (en) 2006-12-01 2008-10-01 Transcu Ltd Systems, devices and methods for powering and/or controlling transdermal delivery devices
RU2517241C2 (ru) 2008-06-19 2014-05-27 Лтс Ломанн Терапи-Зюстеме Аг Композиция для чрескожной доставки катионных действующих веществ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
EP0612253A4 (de) * 1991-11-12 1995-08-09 Nepera Inc Anklebenok hydrogele mit verlängerter lebensdauer und verfahren zu ihrer herstellung.
ATE255450T1 (de) * 1995-06-09 2003-12-15 Hisamitsu Pharmaceutical Co Matrix für iontophorese

Also Published As

Publication number Publication date
CN1171269A (zh) 1998-01-28
CA2208332A1 (en) 1997-12-20
EP0813879A2 (de) 1997-12-29
EP0813879A3 (de) 1998-10-14
DE69716676D1 (de) 2002-12-05
EP0813879B1 (de) 2002-10-30
DE69716676T2 (de) 2003-03-20

Similar Documents

Publication Publication Date Title
US5091171B1 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
DE69833000D1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
ATE255450T1 (de) Matrix für iontophorese
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
DE69317494D1 (de) Zusammensetzungen, die mono oder polyhydroxylierte Aminosäuren zur Behandlung des Insulinunabhängigen Diabetes Mellitus enthalten
ATE369150T1 (de) Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
PT1039802E (pt) Dispositivo terapeutico transdermico contendo capsaicina e analogos da capsaicina.
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
EA199900448A1 (ru) Производные 6-фенилпиридил-2-амина, полезные в качестве ингибиторов nos
ATE193302T1 (de) Glutathionanaloge und paraloge mischungen aus glutathion-ähnlichen substanzen
ATE149349T1 (de) Einarbeitung eines poly-n-vinylamids in ein transdermales system
EA200000652A1 (ru) Кристаллы глюкагоноподобного пептида 1
PT969843E (pt) Composicoes antitussicas contendo teobromina
AU2101800A (en) Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
EA200000165A1 (ru) Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos
DE69501105D1 (de) L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
ATE226832T1 (de) Mittel zur arzneistoffverabreichung durch iontophorese
ATE208144T1 (de) Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE294568T1 (de) Zusammensetzung zur behandlung von verbrennungen
EP2078525A3 (de) Behandlung der Tuberkulose mit immunmodulatorischen Verbindungen
EA200501591A1 (ru) Фармацевтическая комбинация для лечения мышечной спастичности и/или боли
DE60141632D1 (de) Zusammensetzung zur stabilisierung von fettlöslichen vitaminen in wässeriger lösung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties